A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men | Zendy

Margaret May | Zendy; Jonathan A C Sterne | Zendy; M Shipley | Zendy; Eric J. Brunner | Zendy; Ralph B. D’Agostino | Zendy; Peter H. Whincup | Zendy; Yoav BenShlomo | Zendy; Andrew Carr | Zendy; Bruno Ledergerber | Zendy; Jens Lundgren | Zendy; A. N. Phillips | Zendy; Joseph M. Massaro | Zendy; Matthias Egger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men

Author(s) -

Margaret May,

Jonathan A C Sterne,

M Shipley,

Eric J. Brunner,

Ralph B. D’Agostino,

Peter H. Whincup,

Yoav BenShlomo,

Andrew Carr,

Bruno Ledergerber,

Jens Lundgren,

A. N. Phillips,

Joseph M. Massaro,

Matthias Egger

Publication year - 2007

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dym135

Subject(s) - medicine , antiretroviral therapy , coronary heart disease , human immunodeficiency virus (hiv) , insulin resistance , disease , cardiology , immunology , viral load , insulin

Many HIV-infected patients on highly active antiretroviral therapy (HAART) experience metabolic complications including dyslipidaemia and insulin resistance, which may increase their coronary heart disease (CHD) risk. We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research